We invite passionate minds in the Vascular field with insightful studies, groundbreaking research or compelling perspective to share to submit their abstract.
The timeline for submission is from March 1st to June 10th, 2026.
Please follow the guideline below or download the guideline here.
Abstract Submission Guidelines
General Policy
There is no submission fee required to submit an abstract to 6th Indovascular.
Registration to the main symposium is a must for all accepted abstracts.
Abstract must be submitted electronically through our website at www.indovascular.org by 11.59 P.M. Western Indonesia Time (WIB) on Jun 10th, 2026. Other method of submittance will not be accepted.
The submitting author is automatically designed as the primary/presenting author.
Abstract submitters will get an email confirmation of notification.
There is no limit to the number of abstracts a person may submit.
The overall quality of language used should assure comprehension by the reader.
Incomplete submissions cannot be processed.
All abstract submitted are subject to disclosure to members of the Peer Review Selection Committee.
Abstract grading is blinded and abstracts are selected on the basis of merit.
Submitters may revise information, correct typographical errors, tables graphics, or withdraw an abstract any time before 11:59 P.M. Western Indonesia Time (WIB) on Jun 10th, 2026. Please contact indovascular22@gmail.com to revise or withdraw an abstract.
The 6th Indovascular committee is unable to reimburse abstract submitters for travel, hotel, and per diem expenses.
Abstract Title
Abstract titles should be concise and should not contain abbreviations. Please use correct Title Case and make sure to bold the entire title.
Abstract Author
All individuals listed as authors should qualify for authorship and should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Authors included in the manuscript should meet all of the following conditions:
· substantial contributions to the conception and design, acquisition of data, or analysis and interpretation of data
· drafting the article or revising it critically for important intellectual content
· final approval of the version to be published. Any other contributors to the work who do not qualify for authorship should be listed in an acknowledgement section.
List of author(s), institute(s), city, and country should be written immediately below the title. Institute(s), city, and country should be written in Italic and Authors name should be listed by initials followed by surname only. First author name should be underlined.
Example:
A. Prasetyawan1 , F. M. Marck2
1Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; 2National Cardiovascular Heart Center Hospital, Jakarta, Indonesia
Abstract Text
Abstract must be submitted in English.
Use Times New Roman for the text font and Symbol for the Greek and special characters.
The numbers of words should not exceed 300 without titles, authors, and organization.
Supported file formats are MS Word and Word Document (.doc or .docx), other file formats will not be processed.
Figures and images must be uploaded separately. Supported file format is JPG or JPEG. The maximum numbers figures and/or images submitted are 2 for each abstract.
Use zeros before decimal points, use dot (.) for marking decimal points, use lower case “p” values. Example p<0.05.
Provide manufacturer name and location in parentheses for all brand or trade names. For brand drugs, include generic names in parentheses.
Do not include references, credits, or grant support. Abstract Policies and Procedures
Abstract Content
For Original Research abstract should be formatted with the following headings:
1. Aims or Background
2. Methods
3. Results
4. Conclusion
5. Keywords, A maximum of six keywords may be submitted.
For Case Report abstract should be formatted with the following headings:
1. Introduction
2. Case Illustration
3. Discussion
4. Summary
5. Keywords